JNE Partners LLP - Q3 2022 holdings

$173 Million is the total value of JNE Partners LLP's 13 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 21.4% .

 Value Shares↓ Weighting
ATVI  ACTIVISION BLIZZARD INC$45,214,000
-4.5%
608,2000.0%26.16%
-15.4%
MU NewMICRON TECHNOLOGY INC$35,456,000707,700
+100.0%
20.52%
NSIT  INSIGHT ENTERPRISES INC$18,377,000
-4.5%
223,0000.0%10.63%
-15.4%
MSDAU  MSD ACQUISITION CORPunit 03/25/2026$14,865,000
+0.4%
1,500,0000.0%8.60%
-11.0%
ORIAU  ORION BIOTECH OPPORTUNTES COunit 04/15/2025$14,775,000
+0.1%
1,500,0000.0%8.55%
-11.3%
EOCWU  ELLIOTT OPPORTUNITY II CORPunit 99/99/9999$10,857,000
+0.7%
1,100,0000.0%6.28%
-10.8%
NG  NOVAGOLD RES INC$9,169,000
-2.5%
1,955,0470.0%5.31%
-13.6%
BABA  ALIBABA GROUP HLDG LTDsponsored ads$6,559,000
-29.6%
82,0000.0%3.80%
-37.7%
BATRK  LIBERTY MEDIA CORP DEL$5,555,000
+14.6%
202,0000.0%3.22%
+1.5%
RKTAU  ROCKET INTERNET GRWT OPRT COunit 99/99/9999$4,251,000
+1.0%
430,2340.0%2.46%
-10.5%
UHAL  AMERCO$3,259,000
+6.5%
6,4000.0%1.89%
-5.7%
KAHCU  KKR ACQUISITION HOLDING I COunit 99/99/9999$2,266,000
-0.3%
229,8660.0%1.31%
-11.7%
W  WAYFAIR INCcl a$2,207,000
-25.3%
67,8000.0%1.28%
-33.8%
WALDW ExitWALDENCAST ACQUISITION CORP*w exp 03/11/202$0-333,333
-100.0%
-0.16%
WALD ExitWALDENCAST ACQUISITION CORP$0-1,000,000
-100.0%
-6.43%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
NOVAGOLD RES INC16Q3 202334.9%
AMERCO11Q3 202240.0%
ELLIOTT OPPORTUNITY II CORP9Q2 202319.8%
COMCAST CORP NEW8Q1 202223.5%
ORION BIOTECH OPPORTUNTES CO8Q1 202311.1%
MSD ACQUISITION CORP8Q4 202211.1%
LIBERTY MEDIA CORP DEL8Q2 202313.9%
ROCKET INTERNET GRWT OPRT CO8Q4 20223.2%
KKR ACQUISITION HOLDING I CO7Q3 20221.7%
MICRON TECHNOLOGY INC5Q3 202356.9%

View JNE Partners LLP's complete holdings history.

Latest significant ownerships (13-D/G)
JNE Partners LLP Q3 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Prevail Therapeutics Inc.January 29, 2021? ?

View JNE Partners LLP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-15
13F-HR2021-11-15

View JNE Partners LLP's complete filings history.

Compare quarters

Export JNE Partners LLP's holdings